AURORA, ON–(Marketwired – Dec 13, 2013) – Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced financial results for the three-month period ended October 31, 2013.
- 0 Comments
- FY2014